Parkinson's disease at forefront of Bayer bet on cell and gene therapies

Bayer's pioneering cell and gene therapies for Parkinson's disease are at the forefront of an exciting but risky test of CEO ...
DrBicuspid

Bayer launches new aspirin for faster pain relief

Bayer Advanced aspirin was tested in multiple sites on dental patients who had just had wisdom teeth extracted. The company said 500 mg of the new aspirin started working in 16 minutes and brought ...
Joplin Globe

Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer

Bayer announced today initiation of dosing in a Phase I first-in-human clinical study with 225 Ac-PSMA-Trillium (BAY 3563254), a next-generation targeted alpha therapy. The investigational candidate, ...
Post-Bulletin

Bayer buying Monsanto, will create global chemical, ag giant

American seed and weed-killer company Monsanto and German medicine and farm chemical maker Bayer are combining in a deal that could help farmers produce higher yields to address challenges from global ...
Reuters

Bayer starts selling quick-release aspirin

CHICAGO (Reuters) - German drugmaker Bayer has released a souped-up version of Bayer aspirin that the company says relieves pain twice as fast as its namesake brand, the company said on Monday. The ...
Morningstar

Bayer Initiates Phase I Study Targeting GPC3 With Actinium-225 Radiopharmaceutical in Patients With Advanced Hepatocellular Carcinoma

Bayer announced today initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha radiopharmaceutical being developed to treat tumors expressing Glypican-3 ...
Time

This Isn’t Your Mother’s Bayer Aspirin

The name Bayer has become highly recognizable, if you’re in the market for aspirin — and you’re about 60. That’s because the company has been so successful at marketing the drug for the prevention of ...